{
  "id": "53443b13aeec6fbd0700000e",
  "type": "yesno",
  "question": "Can a peptide aptamer be used as protein inhibitor?",
  "ideal_answer": "Yes, peptide aptamers can be used as inhibitors.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/20842131",
    "http://www.ncbi.nlm.nih.gov/pubmed/21296653",
    "http://www.ncbi.nlm.nih.gov/pubmed/22811618",
    "http://www.ncbi.nlm.nih.gov/pubmed/22956136",
    "http://www.ncbi.nlm.nih.gov/pubmed/17917077",
    "http://www.ncbi.nlm.nih.gov/pubmed/16581027",
    "http://www.ncbi.nlm.nih.gov/pubmed/18195017",
    "http://www.ncbi.nlm.nih.gov/pubmed/19150354",
    "http://www.ncbi.nlm.nih.gov/pubmed/22714536",
    "http://www.ncbi.nlm.nih.gov/pubmed/10439043",
    "http://www.ncbi.nlm.nih.gov/pubmed/19389625",
    "http://www.ncbi.nlm.nih.gov/pubmed/24130701",
    "http://www.ncbi.nlm.nih.gov/pubmed/18186614",
    "http://www.ncbi.nlm.nih.gov/pubmed/20191379",
    "http://www.ncbi.nlm.nih.gov/pubmed/12123800",
    "http://www.ncbi.nlm.nih.gov/pubmed/22533554",
    "http://www.ncbi.nlm.nih.gov/pubmed/16815302",
    "http://www.ncbi.nlm.nih.gov/pubmed/16139842",
    "http://www.ncbi.nlm.nih.gov/pubmed/24188027"
  ],
  "snippets": [
    {
      "text": "Peptide aptamers of LIM-only protein 2 (Lmo2) were previously used to successfully treat Lmo2-induced tumours in a mouse model of leukaemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24188027",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10439043",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Accumulating work over the past decade has shown that peptide aptamer screening represents a valid strategy for inhibitor identification that can be applied to a variety of different targets. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22956136",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": ". The target of one inhibitor peptide, Pep80, identified in this screen was determined to be Snapin, a protein associated with the soluble N-ethyl maleimide sensitive factor adaptor protein receptor (SNARE) complex that is critical for calcium-dependent exocytosis during neurotransmission. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24130701",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of the genetically selected intracellular aptamer inhibitors allowed us to define unique mechanisms important to HIV-1 replication and T cell biology.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24130701",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This review will describe pre-clinical and clinical data of four major classes of TGF-\u03b2 inhibitor, namely i) ligand traps, ii) antisense oligonucleotides, iii) receptor kinase inhibitors and iv) peptide aptamers. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22811618",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " A peptide aptamer (ID1/3-PA7) has been designed to prevent this interaction and thereby leading to the transcription of p16(INK4a).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22714536",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A peptide kinase inhibitor (IP(20)) was used as the aptameric peptide ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22533554",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Peptide aptamer mimicking RAD51-binding domain of BRCA2 inhibits DNA damage repair and survival in Trypanosoma brucei.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21296653",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " peptide aptamer, Id1/3-PA7, targeting Id1 and Id3,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20842131",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20191379",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19389625",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Our approach thus demonstrates that peptide aptamers are potent inhibitors that can be used to interfere with RhoGEF functions in vivo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19389625",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Development of systemic in vitro evolution and its application to generation of peptide-aptamer-based inhibitors of cathepsin E.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19150354",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "he fusion peptide, TA aptamer, was observed within PC12 cytoplasm and maintained both Abeta-binding ability and antioxygenic property similar to TRX.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17917077",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17917077",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In order to efficiently select aptamers that bind to and inhibit proteins,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16815302",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16815302",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This demonstrates the utility of this strategy for screening aptamers based on their inhibitory actions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16815302",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Intracellular expression of the DRD-binding peptide aptamer specifically suppressed receptor-mediated extrinsic apoptosis but not intrinsic pathway, which was recapitulated by the antisense oligonucleotides for FLASH. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16581027",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Peptide aptamers are peptides constrained and presented by a scaffold protein that are used to study protein function in cells. They are able to disrupt protein-protein interactions ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16139842",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we have used a genetic screen in yeast to select in vivo peptides coupled to thioredoxin, called aptamers, that could inhibit GEFD2 activity. One aptamer, TRIAPalpha (TRio Inhibitory APtamer), specifically blocks GEFD2-exchange activity on RhoA in vitro.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12123800",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results show that cell proliferation can be inhibited using genetically-selected synthetic peptides that specifically target protein-protein interaction motifs within cell cycle regulators.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10439043",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These data highlight the utility of peptide aptamers to identify novel binding interfaces and highlight a role for MAP1B in DAPK-1-dependent signaling in autophagy and membrane blebbing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18195017",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/INH_BPT4",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010455",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011500",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D052158"
  ],
  "exact_answer": "Yes"
}